Topical mitomycin-C for the treatment of anal stricture

被引:19
|
作者
Mueller, Claudia M. [1 ]
Beaunoyer, Mona [2 ]
St-Vil, Dickens [2 ]
机构
[1] Stanford Univ, Div Pediat Surg, Sch Med, Stanford, CA 94305 USA
[2] Univ Montreal, Hop St Justine, Dept Surg, Montreal, PQ H3T 1C5, Canada
关键词
Anal stricture; Anal dilatation; Mitomycin-C; ESOPHAGEAL STRICTURES; TRACHEAL STENOSIS; SURGERY; REOPERATIONS; SAFETY;
D O I
10.1016/j.jpedsurg.2009.10.038
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Background: Anal stricture is a well-known and feared consequence of anorectal surgery. Daily dilatations are often prescribed in the immediate postoperative period to avoid stricture of the anus. Nonetheless, stricture may still occur and, particularly in older children, may require multiple dilatations under anesthesia. Topical mitomycin-C has been found to be effective in the treatment of strictures at various anatomical locations. In this article, we review our experience with topical mitomycin-C as an adjunct to anal dilatation for children with anal stricture. Materials and methods: Cases of children with anal stricture who were treated with a single application of topical mitomycin-C as an adjunct to anal dilatation between 2000 and 2008 were analyzed retrospectively. Anal diameter was measured with Hegar dilators. Cottonoid swabs soaked in mitomycin-C were placed on the anal mucosa for 5 minutes after dilatation. Treatment success was defined by sustained improvement in anal size, decrease in symptoms, parental satisfaction, and need for additional intervention. Results: Ten children with anal stricture who underwent anal dilatation with application of topical mitomycin-C were identified. All children presented with severe constipation. Average increase in anal size after dilatation under sedation was 5.7 mm (+/- 3.2 mm). Average improvement in anal diameter on first clinic visit after mitomycin-C application was 3.7 mm. On follow-up, only 1 child required repeated intervention for stricture after treatment with mitomycin-C. No complications were associated with the use of mitomycin-C. Conclusions: All children treated with mitomycin-C showed early improvement in their anal size after dilatation under sedation. A single application of topical mitomycin-C allowed them to retain an increased anal diameter over time and avoid additional dilatations. Furthermore, the application of mitomycin-C in our population was straightforward and safe. Therefore, we advocate its use as an adjunct to anal dilatation under sedation in the treatment of severe anal stricture. (C) 2010 Elsevier Inc. All rights reserved.
引用
收藏
页码:241 / 244
页数:4
相关论文
共 50 条
  • [41] The efficacy of mitomycin-C in the treatment of laryngotracheal stenosis
    Simpson, C. Blake
    James, Joshua C.
    LARYNGOSCOPE, 2006, 116 (10): : 1923 - 1925
  • [42] Impact of Mitomycin-C application time on the scleral Mitomycin-C concentration
    Vass, C
    Georgopoulos, M
    El Menyawi, I
    Radda, S
    Nimmerrichter, P
    JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2001, 17 (02) : 101 - 105
  • [43] Preservation of function and histologic appearance in the injured glottis with topical mitomycin-C
    Spector, JE
    Werkhaven, JA
    Spector, NC
    Huang, S
    Page, RN
    Baranowski, B
    Luther, M
    McGehee, B
    Reinisch, L
    LARYNGOSCOPE, 1999, 109 (07): : 1125 - 1129
  • [44] EPIDERMOID ANAL CANCER - TREATMENT BY RADIATION ALONE OR BY RADIATION AND 5-FLUOROURACIL WITH AND WITHOUT MITOMYCIN-C
    CUMMINGS, BJ
    KEANE, TJ
    OSULLIVAN, B
    WONG, CS
    CATTON, CN
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1991, 21 (05): : 1115 - 1125
  • [45] Intumescent cataract after topical mitomycin-C for conjunctival malignant melanoma
    Sacu, S
    Ségur-Eltz, N
    Horvat, R
    Lukas, JR
    Zehetmayer, M
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2003, 136 (02) : 375 - 377
  • [46] Nanophthalmic uveal effusion managed with scleral windows and topical mitomycin-C
    Akduman, L
    Adelberg, DA
    DelPriore, LV
    OPHTHALMIC SURGERY AND LASERS, 1997, 28 (04): : 325 - 327
  • [47] AN IN-VIVO STUDY OF SUBCONJUNCTIVAL TISSUE RESPONDS TO TOPICAL MITOMYCIN-C
    KIRCHHOF, B
    MIETZ, H
    DIESTELHORST, M
    KRIEGLSTEIN, GK
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1994, 35 (04) : 1427 - 1427
  • [48] Intraoperative episcleral versus postoperative topical application of mitomycin-C for trabeculectomies
    Mietz, H
    Jacobi, PC
    Krieglstein, GK
    OPHTHALMOLOGY, 2002, 109 (07) : 1343 - 1349
  • [49] Topical mitomycin-C for subepithelial fibrosis after refractive corneal surgery
    Majmuder, PA
    Forstot, SL
    Dennis, RF
    Nirankari, VS
    Damiano, RE
    Brenart, R
    Epstein, RJ
    OPHTHALMOLOGY, 2000, 107 (01) : 89 - 94
  • [50] Prevention of anterior glottic restenosis in a canine model with topical mitomycin-C
    Spector, JE
    Werkhaven, JA
    Spector, NC
    Huang, S
    Sanders, D
    Reinisch, L
    ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY, 2001, 110 (11): : 1007 - 1010